Curiox Biosystems Co., Ltd (KOSDAQ:445680)

South Korea flag South Korea · Delayed Price · Currency is KRW
90,700
+100 (0.11%)
At close: Apr 27, 2026
268.70%
Market Cap 1.61T
Revenue (ttm) 5.15B
Net Income (ttm) -27.18B
Shares Out 17.12M
EPS (ttm) -1,645.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 71,565
Average Volume 157,294
Open 90,200
Previous Close 90,600
Day's Range 90,000 - 92,400
52-Week Range 23,050 - 149,200
Beta 2.80
RSI 50.94
Earnings Date May 15, 2026

About Curiox Biosystems

Curiox Biosystems Co., Ltd manufactures and sells automated equipment and consumables for cell analysis processes in South Korea. It offers C-FREE Pluto systems, including Pluto workstation, an Automated Antibody Cocktailing and Cell Staining in One Station; Pluto ALPHA, a Centrifuge-free cell washing; Pluto Code, a software script that brings Curiox’s centrifuge-free washing technology. The company offers other products & accessories, including C-FREE Gripper, C-FREE Tilter, DropArray Station, DropArray Bead Plates, MINI 1000 System, HT2100 Sy... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2018
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 445680
Full Company Profile

Financial Performance

In 2025, Curiox Biosystems's revenue was 5.15 billion, an increase of 12.29% compared to the previous year's 4.59 billion. Losses were -27.18 billion, 236.0% more than in 2024.

Financial Statements

News

There is no news available yet.